Background: The aim of this study was to understand the factors influencing the use of surgical options by New Zealand women with newly diagnosed breast cancer. Methods: Using data from the Auckland and Waikato breast cancer registers, we included 11 798 women diagnosed with stage I-III breast cancer from June 2000 to May 2013. The characteristics of women receiving different surgical treatments and having immediate breast reconstruction following mastectomy were examined. A logistic regression was used to estimate the odds ratio of having breast-conserving surgery (BCS) versus mastectomy and immediate post-mastectomy reconstruction. Bilateral breast cancer cases and women with unilateral breast cancer, but who had bilateral surgery, were also identified. Results: Fifty-two percent of women received BCS and 44% had mastectomy over the study period. Key influences associated with BCS were age, mode of diagnosis, socioeconomic status and public or private treatment. Just under half of the women who underwent bilateral surgery did not have bilateral cancer. Nineteen percent of women undergoing mastectomy underwent immediate reconstruction. Implant use increased slightly over the study period but there was a decrease in the use of autologous flap procedures. Conclusion: Surgical management of women with localized breast cancer was generally in line with guidelines, but with potential to further increase the use of breast conservation and immediate reconstruction in suitable cases.
Introduction
New Zealand (NZ) has a population of 4.5 million, of which 1.9 million live in and about the Auckland and Waikato regions. Three thousand NZ women are diagnosed with breast cancer each year. The primary treatment for 95% of women with localized breast cancer is surgery. Historically, surgical treatment has involved mastectomy, 1 but in 1990 the National Institutes of Health Consensus Conference recommended breast-conserving surgery (BCS) followed by radiotherapy (RT) as the treatment of choice for early stage breast cancer in suitable cases. 2 These recommendations led to a steady increase in the uptake of BCS. 3 More recently, however, rates of mastectomy have been seen to increase in the USA, 4 even in women with breast cancer that is suitable for BCS. 5 Reasons why women choose BCS or mastectomy are multifactorial. Factors influencing decision-making include surgeon opinion, 6 tumour size (and size relative to breast size) and location, 7 access to RT, 8 socio-economic status and education level, 9 ethnicity, 10 comorbidity, 11 use of preoperative magnetic resonance imaging, 4 BReast CAncer gene (BRCA) status 8 and family history. 6 Fear of recurrent cancer is an important factor driving the uptake of mastectomy, which offers a perception of reduced risk and avoidance of repeat treatments or RT associated with BCS. 6 In contrast, BCS is perceived as less radical, with a positive cosmetic outcome and body image. 2, 6 From a surgical perspective, more women are becoming suitable for BCS with growing training and use of oncoplastic techniques, including reduction or volume replacement techniques.
A small number of women are diagnosed with cancer in both breasts and undergo bilateral surgery -usually bilateral mastectomy. In some cases, women with unilateral disease choose bilateral mastectomy to prevent cancer in the other breast, 5 
Methods
This study is based on data from two cancer registers (Auckland and Waikato), which have prospectively collected data from almost 100% of newly diagnosed breast cancer cases. Data are entered on to the registers through clinic and operation records, multidisciplinary meeting records, oncology, palliative care and private and public hospital records. 15 We The presence of co-morbidities was ascertained by data linkage to the National Minimum Dataset (NMDS) that records clinical data for inpatients and day patients. We characterized patients as having no co-morbidities (C0), one co-morbidity (C1) or 2 or more (C2+) using the C3 co-morbidity count. 16 Surgical choices were categorized as either BCS, mastectomy or no primary surgery. We recorded surgery to one or both breasts, and whether women choosing mastectomy opted for breast reconstruction. Reconstructive surgery was categorized as DIEP/TRAM flaps, LD flaps or implants/expanders. We identified bilateral breast cancer cases and women who had unilateral breast cancer but had bilateral surgeries. Descriptive statistics for categorical variables are displayed as actual numbers/percentages and compared between groups using chi-squared tests. All tests of significance were two tailed, with P < 0.05 considered significant. Sociodemographic and disease factors associated with the receipt of BCS (versus mastectomy), as well as the receipt of post-mastectomy breast reconstruction were determined using logistic regression to obtain odds ratios (ORs). All statistical analyses were performed in SPSS version 23 (IBM Corporation, New York, NY, USA).
Ethical approval for the study was granted through the Northern A Health and Disability Ethics Committee (reference: 12/NTA/ 42/AM01).
Results

Primary surgery
Of the 11 798 women diagnosed with stage I-III breast cancer between June 2000 and May 2013, 6149 (52%) women had BCS, 5179 (44%) had mastectomy and 470 (4%) had no primary surgery ( Table 1 ). The probability of having BCS compared to mastectomy was greatest in the screening age range and decreased with age ( 
Breast reconstruction after mastectomy
After mastectomy, 972 (19%) women had immediate breast reconstruction: 434 (45%) DIEP or TRAM flaps, 131 (13%) LD flaps and 407 (42%) implant/expander reconstruction ( Table 3 Logistic regression showed that ethnicity, public/private hospital, having post-mastectomy RT, region, cancer stage, co-morbidity, screen detection, age and year of diagnosis had a significant impact on the likelihood of having breast reconstruction following mastectomy (Table 4 
Bilateral cancer and bilateral surgeries
We found 295 (3%) women diagnosed with bilateral breast cancer, including 236 from Auckland and 59 from Waikato. Of these, 174 (59%) women had bilateral mastectomy, 82 (28%) had bilateral BCS, 17 (6%) had BCS and mastectomy on each side and 22 (8%) had no primary surgery. After bilateral mastectomy, 51 (29%) had immediate bilateral breast reconstruction.
There were 290 (2%) women diagnosed with unilateral breast cancer, but who underwent bilateral surgery, including 242 from Auckland and 48 from the Waikato. Of these, 285 (98%) women had a bilateral mastectomy. Following bilateral mastectomy, 79 (28%) had immediate bilateral breast reconstruction. The rates of bilateral mastectomy in women diagnosed with unilateral breast cancer increased over time (1.3% during 2000-2003 to 3.7% during 2010-2013).
Discussion
Mastectomy is still used in women with primary breast cancer that is potentially suitable for BCS. In this NZ cohort, we found slightly more use of BCS, with 52% of women receiving BCS while 44% of women received a mastectomy. More use of BCS is in contrast to reports of a steady rise in the use of mastectomy in the USA, 3, 4 but is in accordance with the Australian BCS rates of 61% over similar time periods. 17 Women diagnosed through screening, even after adjustment for age and stage, were twice as likely to receive BCS, while only 29% underwent a mastectomy. In 2004, the eligible age range for screening in NZ was widened to include women aged 45-49 years in addition to the 50-69 year age group, which It has been reported elsewhere that younger women, particularly <40 years of age, are more likely to choose mastectomy. [3] [4] [5] We report similar data, with 61% of women aged <40 years opting for mastectomy. Younger women have a higher likelihood of being BRCA gene mutation positive 4, 5 and have a higher risk of local recurrence after BCS. Fear of recurrence has a major influence on decision-making for this age group. Women older than the NZ screening range (45-69 years) were also more likely to choose mastectomy. Women living in the Waikato region were more likely to be treated with BCS, even after adjustment for stage, grade and size of tumour. Surgeon or system differences could account for some of the variation in the type of surgery chosen. The level of surgeon influence on women's surgery decisions is a significant factor in published studies. 3, 6, 10, 20 Patients treated publicly and those living in the most deprived socio-economic quintile (9, 10) were less likely to receive BCS. Social deprivation likely plays a role in decision-making 8, 9 and lower rates of breast reconstruction 21 and may also indirectly relate to differences in surgical treatment between the public and private sectors. 10 Only 586 women underwent bilateral surgery, and 290 (50%) of these did not have bilateral cancer. Bilateral mastectomy reduces the risk of contralateral breast cancer following unilateral disease, but does not increase survival in BRCA1/2 mutation negative women. 12 Reasons why women choose bilateral surgery are related to clinical, psychological and cosmetic outcomes, 12 anxiety surrounding future treatments, family history 9 and being BRCA or other gene mutation positive. 22 Fear of recurrence and a misperception of enhanced survival are major influences, 12 with younger women more anxious than older women 23 and therefore more likely to opt for bilateral mastectomy. 9, 22, 23 In the current cohort, 80% of women who had unilateral breast cancer but opted for bilateral surgery were <60 years of age, and as age increased, the likelihood of having a bilateral mastectomy decreased. The uptake of breast reconstruction has been increasing slowly over time. 13 In this cohort, immediate reconstruction increased from 17% to 21% at the end of the study period. This compares to a rate of 12-16% in Australia, 24 an average regional rate of 21% in the UK 25 and 26% in the USA. 26 In our study, the crude percentages of reconstruction between the two NZ regions were similar, but the OR for breast reconstruction in the Waikato was 40% higher than in Auckland after adjusting for greater deprivation and use of postmastectomy RT in the Waikato. Regional differences can be due to a mixture of patient factors (age and social deprivation), system factors (size and location of treatment facilities) and surgeon preferences (e.g. timing and suitability for reconstruction, and preferred method such as implants alone versus use of LD flaps).
Regional differences have also been reported in the USA, where up to 84% of Caucasian women in areas with a high density of plastic surgeons and private insurance undergo immediate reconstruction. 27 Women identified through breast screening but who chose mastectomy were also more likely to have reconstruction. There are many possible reasons for this, including, higher health literacy, fewer M aori and Pacific women in this population and a higher proportion of screened women having tumours that do not require RT, for example, extensive ductal carcinoma in situ. Compared with NZ European, M aori and Pasifika women were significantly less likely to undergo breast reconstruction. Ethnic disparities have been reported previously 10 and may in part be influenced by factors such as smoking and obesity. Other factors influencing whether women receive reconstruction (but not addressed in this study) include living remotely, 28 surgeon caseloads or large tumour size. 24 There was a decrease in the use of autologous procedures (DIEP, TRAM and LD flaps) and an increase in the use of implants from 12% during 2000-2003 to 56% during 2010-2013 (Table 3) . This trend has also been reported elsewhere 29 and is likely due to improvements in implant techniques, with growing use of acellular dermal matrices and subsequent use of fat grafting, whilst avoiding the morbidity associated with autologous methods. Autologous procedures also often involve specialist plastic surgical input, which additionally makes the scheduling and timely provision of surgery more difficult.
The relatively large sample is a strength of this study. The sample was derived from generally complete population-based data sets. A limitation is that we restricted our analysis on breast reconstruction to immediate surgeries, as we were concerned that there may be an under-recording of delayed surgical intervention. However, we believe the proportion of delayed breast reconstruction is <10% of the total.
This study examines the different surgical options used in a large cohort of NZ women with newly diagnosed breast cancer. We have shown slightly more use of BCS over the study period, perhaps explained by the increase in diagnoses through screening. Mastectomy was more likely in older women, but more women in the <40 year age group were also opting for mastectomy, which is in accordance with trends reported elsewhere. Almost 3% of women underwent bilateral mastectomy despite having unilateral breast cancer. We report growing rates of immediate breast reconstruction, with an increase in implant-based reconstruction techniques. By international standards, there is room for improvement in both breast conservation rates and use of immediate breast reconstruction.
